Shire Sues Impax, Watson Over Generic Intuniv
Irish pharmaceutical maker Shire PLC is fighting yet again to protect sales of its attention deficit hyperactivity disorder drug Intuniv, filing a suit against Impax Laboratories Inc. and Watson Pharmaceuticals Inc....To view the full article, register now.
Already a subscriber? Click here to view full article